February 22nd, 2012
Abbott Faces More Investigations, Lawsuits Over Depakote Marketing
Abbott Laboratories (ABT) is facing fresh legal challenges in connection with its sales and marketing of anti-seizure drug Depakote.
The Abbott Park, Ill., company last year set aside $1.5 billion to cover a potential settlement stemming from a Justice Department-led investigation of allegations that the company promoted Depakote for unauthorized uses. A final settlement is pending.